S100B and brain cancer: The data obtained because this study are valuable because they expand our general understanding of the potential association between markers of neuronal lesions (S100β), TJ/BBB stability, immune response (as measured by onconeural, anti-neural, and/or anti-nucleosome antibodies), and functional outcomes in the brain cancer patient population.